Omada Health (NASDAQ:OMDA) President Wei-Li Shao Sells 4,589 Shares

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 4,589 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $17.24, for a total transaction of $79,114.36. Following the transaction, the president directly owned 316,238 shares of the company’s stock, valued at approximately $5,451,943.12. This represents a 1.43% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, April 8th, Wei-Li Shao sold 2,829 shares of Omada Health stock. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59.

Omada Health Price Performance

NASDAQ OMDA opened at $17.11 on Wednesday. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92. The company has a 50-day moving average of $15.54 and a 200-day moving average of $14.80. The company has a market cap of $1.02 billion and a P/E ratio of -63.37.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million during the quarter. As a group, equities research analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current year.

Analyst Upgrades and Downgrades

OMDA has been the subject of a number of research analyst reports. Citizens Jmp increased their target price on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research report on Friday, May 8th. JPMorgan Chase & Co. dropped their target price on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a research report on Thursday, March 12th. Evercore reissued an “outperform” rating and set a $20.00 target price on shares of Omada Health in a research report on Friday, May 8th. BMO Capital Markets dropped their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Finally, The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Omada Health has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Hedge Funds Weigh In On Omada Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Quarry LP purchased a new position in Omada Health in the 4th quarter worth approximately $29,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health in the 4th quarter worth approximately $32,000. Raymond James Financial Inc. purchased a new position in Omada Health in the 2nd quarter worth approximately $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health in the 4th quarter worth approximately $45,000. Finally, Strs Ohio boosted its holdings in Omada Health by 151.0% in the 4th quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after acquiring an additional 2,567 shares during the period.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.